BERKELEY, Calif., Feb. 25, 2010 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that company management will participate in two investment conferences in March 2010. Steven B. Engle, Chairman and Chief Executive Officer, will participate in a panel discussion "Building a Proprietary and Partnered Pipeline of Antibodies" on March 3 from 2:05 to 3:00 pm EST during the RBC Capital Markets Healthcare Conference in New York City. Fred Kurland, Vice President and Chief Financial Officer, will present a corporate update on March 8 at 3:15 pm EST during the Cowen and Company 30th Annual Healthcare Conference in Boston.
